Astrea Bioseparations
Advertisement
Articles by Astrea Bioseparations
Sponsored Podcast
Astrea Bioseparations joins Biopharm International for a discussion about the evolving challenges of downstream processing for advanced therapies, and what the future might hold. We talk about the company’s evolution over the last three decades, including the Discover. Develop. Deliver. approach to customer alignment. The latest industry trends are reviewed, along with considerations to keep in mind during the selection of off the shelf or customized downstream solutions.
Advertisement
Latest Updated Articles
Developing Cost-effective, Accelerated Downstream ProcessesAugust 18th 2021
Advertisement
Advertisement
Trending on BioPharm International
1
Merck and Kelun’s Sac-TMT Extends Survival by Nearly 7 Months in Pretreated Endometrial Cancer
2
BMS Reports Death in Phase 1 Zolacabtagene Autoleucel MS Study
3
The BioPharm Brief: Survival Gains, a Modest ADC Win, and CAR-T in Multiple Sclerosis
4
BioNTech’s HER2 ADC Hits Phase 3 Goal, but Companies See Limited Benefit
5